This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on September 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Animal Blood

Closed

CDRH2026134634Federal

Submission Closed09/18/2026, 10:00:00 AM EDT

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

International

Лікарські засоби (МНН: Rabies, inactivated, whole virus) (ІНДІРАБ ВАКЦИНА АНТИРАБІЧНА)

Solicitation # UA-2026-11-06-014068-a

This solicitation, issued by the Rivne Regional Children's Hospital under the Government of Ukraine, is for the procurement of inactivated whole virus rabies vaccines known as Indirab. The procurement process is identified by solicitation number UA-2026-11-06-014068-a, with a response deadline set for November 10, 2026. The performance of the contract will take place in Rivne, Rivne Oblast, Ukraine. Participants in this procurement are required to provide detailed information regarding their ultimate beneficial owners, particularly for non-resident entities. This mandatory disclosure must include the full name, citizenship, and the nature and extent of the beneficial ownership or influence. Additionally, for resident founders, the full name, location, and identification code of the legal entity must be submitted in a free-form format upon signing the contract.

Комунальне підприємство "Рівненська обласна дитяча лікарня" Рівненської обласної ради

POSTED

DEADLINE

Реагенти для лабораторії імуногенетичних технологій та біоінженерії – ДК 021:2015 – 33690000-3 - Лікарські засоби різні (КЛІТИННА ЛІНІЯ Nalm-6-Zellen – Код ДК 021:2015 – 33696500-0 - Лабораторні реактиви (НК 024:2023/НК 031:2024 – 30670 - Лінія клітинної

Solicitation # UA-2026-11-06-013516-a

The National Children's Specialized Hospital Okhmatdyt of the Ministry of Health of Ukraine is soliciting bids for the procurement of laboratory reagents, specifically the Nalm-6 cell line, for the Laboratory of Immunogenetic Technologies and Bioengineering. This solicitation, identified by number UA-2026-11-06-013516-a, is categorized under various medical and laboratory reagent codes. The performance of the contract and delivery of goods will take place in Kyiv, Ukraine. Interested parties must submit their responses by the deadline of November 22, 2026. A critical compliance requirement for this contract is that the goods provided cannot originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Primary contact for this procurement is Maryna Yakymchuk.

Державне некомерційне підприємство «Національна дитяча спеціалізована лікарня «Охматдит» МОЗ України»

POSTED

DEADLINE

ITB- Supply and delivery of AHS veterinary vaccines [email hidden]

Solicitation # 2026/FNSDN/FNSDN/138908

The Food and Agriculture Organization of the United Nations is seeking offers for the procurement and delivery of AHS veterinary vaccines to Chad. This solicitation, identified as 2026/FNSDN/FNSDN/138908, is managed by the FAO procurement team in Sudan. Interested bidders must possess at least a UNGM Basic Registration with FAO to participate. All offers must be submitted exclusively through the UNGM portal to be considered valid, as any submissions made through other channels will be invalidated.

POSTED

DEADLINE

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Solicitation # SPE2DP-26-R-0004

Solicitation SPE2DP-26-R-0004 is a Request for Proposal issued on November 4, 2026, by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of egg-free Influenza Virus Vaccine, 2027-2028 Formula for adults aged 18 and older. The government intends to award a Firm Fixed Price, Indefinite Delivery, Indefinite Quantity contract to the responsible offeror determined to be most advantageous based on price and non-price factors. Proposals must be submitted electronically via the DIBBS system by December 3, 2026. Award criteria include the proposed unit and total price, agreement to all solicitation terms without exception, and, for large businesses, the submission of a Small Business Subcontracting Plan. The contract mandates strict quality and cold chain management standards, requiring vaccines to be maintained between 2 to 8 degrees Celsius during transportation for up to 72 hours with no acceptable excursions. Products must be delivered to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must have an expiration date no later than 18 months after the date of issue from the manufacturer's cold storage. Manufacturers must be FDA current Good Manufacturing Practice acceptable. Packaging and marking must adhere to Medical Marking Standard No. 1D and MIL-STD-129 for perishables. Invoicing and payment will be processed electronically through the Wide Area Workflow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MEDICAL PHARMACY EMERGENCY NON NSN ORDER

Solicitation # SPE2DP-26-R-0003

Solicitation SPE2DP26R0003 is a request for Injectable Influenza Vaccine 2027 issued by the Department of Defense through DLA Troop Support, based in Philadelphia, Pennsylvania. This procurement falls under NAICS code 325414. The solicitation was posted on November 4, 2026, with a response deadline of December 3, 2026, at 8:00 PM. Primary contact for this effort is Rosbert Jones, with Melissa Rios Thomas serving as the secondary point of contact. Proposals must be submitted electronically via the DIBBS system in accordance with FAR 15.208(a). Submissions are subject to strict technical requirements, including a maximum file size of 10 MB per document and a 60-character limit for file names. File names must not contain spaces and may only use hyphens or underscores as special characters. Acceptable file formats include standard document, image, and spreadsheet extensions such as .pdf, .docx, and .xlsx.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Blood Grouping Serum, Anti-A, MonoclonalThis subcontract involves the supply of monoclonal antibody serum to prime contractors supporting DLA Troop Support medical supply contracts. Specifically, the provider is responsible for delivering 2,000 packages of Blood Grouping Serum, Anti-A, Monoclonal (NSN 6550-01-317-0288) in 10 ML vials. The contract is managed under the Department of Defense through the Medical Supply Chain MD Surg FSF. All materials must be packed and marked in accordance with Medical Marking Standard No. 1, MIL-STD-2073-1E, and Special Packaging Instructions MPACG00001. Additionally, the provider must ensure that all hazard labels are fully compliant with 29 CFR 1910.1200. The place of performance for this requirement is designated as APO 09227-0000.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

iPSC Culture and Differentiation

Solicitation # 75N98027Q00053

The National Institutes of Health, specifically the National Institute of Environmental Health Sciences, intends to award a firm-fixed-price purchase order to Creative Biolabs Inc. for iPSC culture and differentiation services. The scope of work involves culturing, differentiating, and expanding cell populations to over 20 million cells, followed by collection and verification. This effort supports a long-term study to sequence and analyze the complex 4q35 locus on Chromosome 4 using Nanopore Sequencing technology. The government is pursuing a sole-source acquisition because Creative Biolabs is identified as the only provider capable of following the specific required protocols and managing the necessary volume of cell lines within a three-month differentiation window. While the intent is to award to a single source, interested parties may submit capability statements to the designated point of contact by November 13, 2026, to demonstrate their ability to meet the technical and operational requirements.

National Institutes Of Health Olao

POSTED

DEADLINE

Scalable Biologic Manufacturing and FormulationThis subcontract focuses on the development of CMC strategies and scalable production processes for biologic therapies supporting prime contractors on NIH/NINDS projects. The scope of work involves utilizing bioreactors and cleanroom facilities to establish manufacturing processes and formulation strategies, ensuring that all quality attributes are validated in accordance with GMP and regulatory standards for clinical application. The successful provider will be responsible for delivering comprehensive scalable manufacturing documentation, formulated drug products, and detailed quality specifications. This effort is managed under the National Institutes of Health within the Department of Health and Human Services, falling under NAICS code 325414 for biologic product manufacturing.

National Institutes Of Health

POSTED

DEADLINE

81627Y0875-Purchase of Raboravel V-RG Vaccines

Solicitation # 20261021008

The New York City Department of Health and Mental Hygiene intends to enter into a six-year agreement with Boehringer Ingelheim Animal Health USA Inc. for the purchase of RABORAL V-RG, a licensed Oral Rabies Vaccine. This vaccine is a critical component of the city's baiting program designed to immunize raccoons and prevent the transmission of rabies to other animals and humans. Boehringer Ingelheim Animal Health USA Inc. has been identified as the sole source provider, as they are the only manufacturer and distributor of USDA-approved oral rabies vaccine baits for raccoons and coyotes in the United States. Interested firms that believe they can legally provide these goods must submit an Expression of Interest via RFI-EPIN 81627Y0875 by November 9, 2026, at 2:00 PM.

Health And Mental Hygiene

POSTED

DEADLINE

81627Y0875-Purchase of Raboravel V-RG Vaccines

Solicitation # 81627Y0875

The New York City Department of Health and Mental Hygiene (DOHMH) is seeking to establish a six-year agreement with Boehringer Ingelheim Animal Health USA Inc. for the procurement of RABORAL V-RG coated sachet baits. This licensed oral rabies vaccine is used in the city's baiting program to immunize raccoons and reduce the transmission of rabies to other animals and humans. DOHMH has identified Boehringer Ingelheim as the sole source provider, as they are the only manufacturer and distributor of USDA-approved oral rabies vaccine baits for raccoons and coyotes in the United States. Under the terms of the agreement, the vendor will provide up to 75,600 individual baits per contract year, sold in quantities of 300. Deliveries must be packed with cold packs and shipped to the NYC Public Health Laboratory at 455 First Avenue, New York, NY 10016, with each shipment accompanied by an invoice. Purchase quantities and delivery schedules will be determined by operational needs, including annual fall baiting campaigns, targeted spring baiting, or emergency responses to rabies outbreaks. Interested firms may submit an Expression of Interest via RFI-EPIN 81627Y0875 by November 9, 2026, at 2:00 PM.

Department Of Health And Mental Hygiene

POSTED

DEADLINE

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Solicitation # 12639527R0001

Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.

POSTED

DEADLINE

Vaccination Campaigns - Procurement of Animal Vaccines.

Solicitation # GC3G2C

The Council for Development and Reconstruction is seeking solicitations for the procurement of animal vaccines to support vaccination campaigns within Lebanon. This federal initiative is managed by the Funding Division, with Oussama Kobeissi serving as the primary point of contact for interested parties. The solicitation, identified by number GC3G2C, was posted on October 22, 2026, and requires responses to be submitted by the deadline of December 3, 2026. All performance of the contract will take place in Lebanon.

Council for Development and Reconstruction

POSTED

18 days ago

DEADLINE

in 24 days

AI Contract Overview

Solicitation 75F40126Q00362 is a Request for Quotation issued by the FDA Center for Devices and Radiological Health for the procurement of donor animal whole blood, specifically bovine, ovine, and porcine species. These products are required to support medical device research and blood compatibility testing, including projects focused on hemolysis and thrombosis. The contract is a total small business set-aside under NAICS code 325414. The performance period consists of a base year running from October 1, 2026, to September 30, 2027, with four subsequent option years extending through September 30, 2031. The contractor must provide whole blood with ACD-A or Na Heparin, ensuring that products are bled and shipped on the same day. Strict technical requirements include AALAC accreditation, ISO 13485:2016 certification, veterinary oversight, and adherence to specific quarantine and labeling protocols. Deliveries are made to the Office of Science and Engineering Laboratories in Silver Spring, Maryland, with inspection and acceptance occurring at the destination. Award is based on a best-value tradeoff, weighing technical capability and past performance approximately equal to price. Invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.

General Info

FDA seeks small business for donor animal whole blood for medical device research.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Silver Spring, MD, 20903, USA

Set-Aside

SBA

Documents

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedSep 16

Combined Synopsis

Response DeadlineSep 18

Deadline has passed

Submission Closed

09/18/2026, 10:00:00 AM EDT

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs

Contacts1 person available

OfficeRockville, MD, 20852, USA

Organization / AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs

Office AddressRockville, MD, 20852, USA

Contacts

Erika Crawford

contact@example.gov

+1 (555) 000-0000

Full Description

This is a synopsis of a procurement for commercial products prepared in accordance with the commercial acquisition procedures of RFO Part 12.

Solicitation No. 75F40126Q00362 was issued as a Request for Quotation (RFQ) for donor animal whole blood (bovine, ovine, and porcine) for the FDA Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Cardiovascular Program, Division of Applied Mechanics (DAM). The blood products support blood compatibility (hemocompatibility) testing and medical device research, including hemolysis- and thrombosis-related projects, as further described in Attachment 1 – Requirements Document.

All supplies shall meet the minimum requirements in Attachment 1 – Requirements Document, including species availability, minimum draw frequency, blood quality, minimum delivery volumes, anticoagulant type, labeling, quarantine protocol, veterinary oversight, AAALAC accreditation, and ISO 13485:2016 certification.